Childhood cancer rates in the United States rose steadily for roughly two decades, driven by a combination of better detection, environmental exposures, shifting demographics, and changes we still don’t fully understand. Between 2001 and 2016, rates climbed across nearly every major category of pediatric cancer before leveling off or declining slightly in more recent years. No single cause explains the trend. Instead, several forces are pushing numbers upward at the same time.
Which Childhood Cancers Are Rising Fastest
Not all pediatric cancers are increasing at the same pace. A National Cancer Institute analysis of U.S. cases from 2001 to 2022 found that epithelial cancers and melanoma contributed the most to the overall rise, followed by leukemias, lymphomas, and brain tumors. Thyroid cancer in children increased about 4.4% per year from 2001 to 2018. Liver tumors rose roughly 2% annually over the full study period. Perhaps most striking, appendix cancer in children showed no change until 2010, then surged more than 61% per year through 2015.
Leukemia, the most common childhood cancer overall, climbed at about 1% per year during the first decade of the study. Lymphoma rates increased more modestly, around half a percent annually. Brain and spinal cord tumors rose at just under 1% per year through 2014. These numbers matter because they point to different causes. A cancer type that spikes suddenly, like appendix cancer, often reflects a change in how doctors look for and classify tumors. A slow, steady rise in leukemia is harder to explain away with detection alone.
Better Detection Finds More Cases
A meaningful portion of the increase is an artifact of improved technology. Advanced imaging, including MRI and PET-CT scans, can now identify small tumors that would have gone undetected a generation ago. Molecular diagnostic tools allow doctors to classify ambiguous growths as cancer that might previously have been labeled benign or simply missed. The dramatic spike in childhood thyroid cancer, for instance, closely tracks the wider availability of ultrasound screening, a pattern seen in adults as well.
This doesn’t mean the cancers aren’t real. It means some of these tumors always existed but weren’t being counted. When a country or region improves its cancer registry, or when a new screening guideline takes hold, reported cases jump even if the actual biological rate hasn’t changed. Globally, cancer registry coverage has expanded significantly. In Africa, childhood population coverage doubled after dedicated pediatric registries were established. In Latin America, coverage grew by more than 6%. Every expansion adds previously invisible cases to the global total, making the worldwide trend look steeper than the biological reality in any single location.
Environmental Exposures and Early-Life Risk
While detection explains part of the picture, it doesn’t account for all of it. A growing body of evidence links prenatal and early-life chemical exposures to elevated cancer risk. A large California case-control study found that children whose mothers lived near agricultural pesticide use during pregnancy had significantly higher odds of developing acute lymphoblastic leukemia, the most common childhood cancer. Exposure to pesticides classified as carcinogenic roughly tripled the risk. Individual chemicals showed their own elevated odds: the herbicide propanil was associated with a 2.6-fold increase, the widely used herbicide glyphosate with a 2.2-fold increase, and the insecticide phosmet with a 2.1-fold increase.
Air pollution also appears to play a role. A Texas registry study of more than 1,300 childhood brain tumor cases found that each moderate increase in fine particulate matter (PM2.5) near a child’s home raised the odds of ependymoma, a type of brain tumor, by 27%. The association held even after accounting for neighborhood greenness and other environmental variables. These pollutant exposures have become more pervasive over the past several decades, particularly in urban and agricultural areas, which could contribute to a genuine biological increase in certain tumor types.
How Environmental Factors Alter Genes
The connection between chemical exposure and cancer isn’t random. Environmental toxins can change how genes behave without altering the DNA sequence itself. These changes, called epigenetic modifications, include chemical tags that silence tumor-suppressing genes or activate genes that promote cell growth. Nutrition, toxicants, and even stress can trigger these modifications.
This mechanism is especially relevant to childhood cancers because the effects can begin before birth. When a pregnant person is exposed to certain chemicals, the developing fetus’s rapidly dividing cells are particularly vulnerable to disrupted gene regulation. One striking example: a specific subtype of ependymoma that occurs mainly in infants has been directly linked to abnormal patterns of gene silencing through epigenetic changes, with no underlying genetic mutation required. The tumor essentially develops because the wrong genes get switched off at the wrong time during early brain development.
Older Parents, Higher Risk
Parental age at conception has shifted upward across most high-income countries over the past 40 years, and this demographic change carries a measurable cancer risk for offspring. A California population study of more than 13 million births found that every five-year increase in maternal age raised the odds of childhood cancer by about 6%. For cancers diagnosed in teenagers, the effect was even larger, at 14% per five-year increment. Paternal age contributed a smaller but still significant 3% increase per five years.
The relationship held across specific cancer types. Each five-year increase in maternal age was associated with a 7% higher risk of childhood leukemia overall and a 6% higher risk of acute lymphoblastic leukemia specifically. Fathers aged 40 and older had children with a 15% elevated risk compared to younger fathers. The biological explanation likely involves accumulated mutations in egg and sperm cells over time, as well as epigenetic shifts that become more common with age. Given that average parental age has climbed steadily in the U.S. and Europe, this factor alone could account for a small but real slice of the upward trend.
Socioeconomic Patterns
Counterintuitively, childhood cancer rates tend to be higher in wealthier families and neighborhoods. A U.S. population study found that each step up in maternal education was associated with an 8% increase in combined childhood cancer incidence. Higher neighborhood socioeconomic status was linked to 9% higher odds overall, with even larger effects for brain tumors (18% higher) and lymphomas (14% higher). The one exception was hepatoblastoma, a rare liver tumor, where higher maternal education was associated with a 30% lower risk.
This pattern likely reflects multiple overlapping factors. Wealthier families have better access to healthcare and are more likely to receive a timely diagnosis, which inflates their apparent incidence rate. But access alone may not be the full explanation. Some researchers have proposed that children in higher-income households may have less early-life exposure to common infections, which could affect immune system development in ways that increase susceptibility to certain cancers, particularly leukemia. The rural-versus-urban divide, interestingly, did not change the socioeconomic pattern, suggesting the association isn’t simply about proximity to medical centers.
The Global Picture Is Complicated
Worldwide trends don’t mirror the U.S. pattern exactly. A 2025 analysis in CA: A Cancer Journal for Clinicians found that the global age-standardized incidence rate of childhood cancer actually declined slightly from 2000 to 2021, falling an average of 0.88% per year. Mortality dropped even faster, at 2.13% annually. This seemingly contradictory finding reflects the enormous influence of data quality. In low-income countries where registry coverage has historically been poor, many childhood cancers simply go unrecorded. As those systems improve, reported cases rise even as the true underlying rate may be stable or falling in some regions.
In high-income countries with long-established registries and consistent diagnostic standards, the upward trend in incidence is harder to dismiss as an artifact. The U.S., Canada, and several European nations have documented real increases in specific cancer types that persist even after adjusting for known diagnostic changes. This suggests that at least some of the rise reflects genuine biological shifts, whether from environmental exposures, demographic changes, or factors researchers haven’t yet identified.